A Ligand for CD5 Is CD5

被引:51
作者
Brown, Marion H. [1 ]
Lacey, Erica [1 ]
机构
[1] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England
基金
英国医学研究理事会;
关键词
CYSTEINE-RICH DOMAIN; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CELL SURFACE-IMMUNOGLOBULIN; POTENTIAL SELECTING LIGAND; RAT T-LYMPHOCYTES; SCAVENGER RECEPTOR; SRCR DOMAIN; MONOCLONAL-ANTIBODY; NATURAL-KILLER; B-CELLS;
D O I
10.4049/jimmunol.0903823
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Recognition by scavenger receptor cysteine-rich domains on membrane proteins regulates innate and adaptive immune responses. Two receptors expressed primarily on T cells, CD5 and CD6, are linked genetically and are structurally similar, both containing three scavenger receptor cysteine-rich domains in their extracellular regions. A specific cell surface interaction for CD5 has been difficult to define at the molecular level because of the susceptibility of CD5 protein to denaturation. By using soluble CD5 purified at neutral pH to preserve biological activity, we show that CD5 mediates species-specific homophilic interactions. CD5 domain 1 only is involved in the interaction. CD5 mAbs that have functional effects in humans, rats, and mice block homophilic binding. Ag-specific responses by mouse T cells in vitro were increased when engagement of human CD5 domain 1 was inhibited by mutation or by IgG or Fab fragment from a CD5 mAb. This showed that homophilic binding results in productive engagement. Enhancement of polyclonal immune responses of rat lymph node cells by a Fab fragment from a CD5 mAb shown to block homophilic interactions provided evidence that the extracellular region of CD5 regulates inhibition in normal cells. These biochemical and in vitro functional assays provide evidence that the extracellular region of CD5 regulates immunity through species-specific homophilic interactions. The Journal of Immunology, 2010, 185: 6068-6074.
引用
收藏
页码:6068 / 6074
页数:7
相关论文
共 44 条
[1]   Towards the definition of a chimpanzee and human conserved CD6 domain 1 epitope recognized by T1 monoclonal antibody [J].
Alonso, Ruby ;
Huerta, Vivian ;
de Leon, Joel ;
Piedra, Patricia ;
Puchades, Yaquelin ;
Guirola, Osmany ;
Chinea, Glay ;
Montero, Enrique .
HYBRIDOMA, 2008, 27 (04) :291-301
[2]   CD6-ligand interactions: a paradigm for SRCR domain function? [J].
Aruffo, A ;
Bowen, MA ;
Patel, DD ;
Haynes, BF ;
Starling, GC ;
Gebe, JA ;
Bajorath, J .
IMMUNOLOGY TODAY, 1997, 18 (10) :498-504
[3]   Cutting edge: Critical role for CD5 in experimental autoimmune encephalomyelitis: Inhibition of engagement reverses disease in mice [J].
Axtell, RC ;
Webb, MS ;
Barnum, SR ;
Raman, C .
JOURNAL OF IMMUNOLOGY, 2004, 173 (05) :2928-2932
[4]   CD5-CK2 binding/activation-deficient mice are resistant to experimental autoimmune encephalomyelitis: Protection is associated with diminished populations of IL-17-expressing T cells in the central nervous system [J].
Axtell, Robert C. ;
Xu, Liang ;
Barnum, Scott R. ;
Raman, Chander .
JOURNAL OF IMMUNOLOGY, 2006, 177 (12) :8542-8549
[5]   CD5 expression is developmentally regulated by T cell receptor (TCR) signals and TCR avidity [J].
Azzam, HS ;
Grinberg, A ;
Lui, K ;
Shen, H ;
Shores, EW ;
Love, PE .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (12) :2301-2311
[6]   Distinct Conformations of Ly49 Natural Killer Cell Receptors Mediate MHC Class I Recognition in Trans and Cis [J].
Back, Jonathan ;
Malchiodi, Emilio L. ;
Cho, Sangwoo ;
Scarpellino, Leonardo ;
Schneider, Pascal ;
Kerzic, Melissa C. ;
Mariuzza, Roy A. ;
Held, Werner .
IMMUNITY, 2009, 31 (04) :598-608
[7]  
Bhandoola A, 2002, EUR J IMMUNOL, V32, P1811, DOI 10.1002/1521-4141(200206)32:6<1811::AID-IMMU1811>3.0.CO
[8]  
2-G
[9]   Identification of a novel inducible cell-surface ligand of CD5 on activated lymphocytes [J].
Biancone, L ;
Bowen, MA ;
Lim, A ;
Aruffo, A ;
Andres, G ;
Stamenkovic, I .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (03) :811-819
[10]   A role for CD5 in cognate interactions between T cells and B cells, and identification of a novel ligand for CD5 [J].
Bikah, G ;
Lynd, FM ;
Aruffo, AA ;
Ledbetter, JA ;
Bondada, S .
INTERNATIONAL IMMUNOLOGY, 1998, 10 (08) :1185-1196